Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: J Appl Biobehav Res. 2014 Jun;19(2):79–105. doi: 10.1111/jabr.12017

Table 2.

Demographic, Clinical, and Treatment Characteristics of the Patients (N = 396)

Characteristic Mean (SD)

Age (years) 54.9 (11.6)

Education (years) 15.7 (2.6)

Self-Administered Comorbidity Questionnaire score 4.3 (2.8)

Karnofsky Performance Status score 93.2 (10.3)

%

Non-white 35.4

Married or partnered 41.5

Lives alone 24.1

Employed 47.5

Postmenopausal 62.3

Stage of disease
   0 18.3
   I 37.9
   IIA, IIB 35.4
   IIIA,IIIB,IIIC,IV 8.3

Neoadjuvant chemotherapy 19.8

Type of surgery
   Breast conservation 79.9
   Mastectomy 20.1

Sentinel lymph node biopsy 82.4

Axillary node dissection 37.4

Underwent reconstruction at time of surgery 21.6

Received adjuvant radiation therapy in first six months 56.6

Received adjuvant chemotherapy in the first six months 33.6

Symptom severity scores prior to surgery Mean (SD)

   Center for Epidemiological Studies-Depression score 13.7 (9.8)

   Trait Anxiety Inventory score 35.3 (9.0)

   State Anxiety Inventory score 41.8 (13.5)

   General Sleep Disturbance Scale score 48.3 (21.6)

   Lee Fatigue Scale - Fatigue score 3.1 (2.4)

   Lee Fatigue Scale - Energy score 4.9 (2.5)

   Attentional Function Index score 6.6 (1.9)